Physician profile
Leslie Ward
NPI 1861695132
$5,134.66
in general payments reported to CMS, 2019-2025
34 companies · $1,919 in 2025
The $1,919 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.19 · 2020: $124 · 2021: $331 · 2022: $330 · 2023: $2,052 · 2024: $346 · 2025: $1,919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,400 · Food and Beverage: $1,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,400.00 |
| Food and Beverage | $1,917.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,037.03 | 2022-2025 | Biktarvy |
| Viiv Healthcare Company | $523.69 | 2023-2025 | Dovato, Cabenuva, Apretude |
| Abbvie INC. | $277.63 | 2021-2025 | Vraylar |
| Novo Nordisk INC | $164.55 | 2021-2024 | Ozempic, Rybelsus |
| Supernus Pharmaceuticals, INC. | $147.47 | 2023-2025 | Qelbree, Qelbree, Tlando |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.85 | 2020-2022 | |
| Pfizer INC. | $98.14 | 2019-2024 | |
| Lilly USA, LLC | $74.89 | 2020-2021 | |
| Amgen INC. | $69.95 | 2021-2022 | |
| Glaxosmithkline, LLC. | $55.49 | 2020-2023 | Trelegy Ellipta |
| Exact Sciences Corporation | $50.08 | 2023-2025 | Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $40.16 | 2025 | |
| Corium, LLC | $35.50 | 2022 | |
| Sunovion Pharmaceuticals INC. | $35.49 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.12 | 2025 | Caplyta |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30.23 | 2025 | Wavewriter Alpha Prime 16 |
| Sanofi Pasteur INC. | $30.21 | 2023-2025 | |
| Ethicon US, LLC | $28.86 | 2024 | Dermabond, Enseal, Endopath Xcel |
| Janssen Pharmaceuticals, INC | $27.81 | 2025 | Invega Sustenna |
| Emd Serono, INC. | $21.60 | 2025 | |
| Axonics, INC. | $20.79 | 2023 | Axonics |
| Braeburn INC. | $20.12 | 2024 | Brixadi |
| Halozyme INC | $19.80 | 2023 | |
| Paratek Pharmaceuticals, INC. | $17.92 | 2023 | Nuzyra |
| Coloplast Corp | $17.37 | 2024 | |
| Hologic Sales and Service, LLC | $14.85 | 2024 | Aptima, Thinprep 2000 Processor |
| Shield Therapeutics INC | $14.16 | 2024 | |
| Convatec INC. | $14.03 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $13.90 | 2020 | |
| Sumitomo Pharma America, INC. | $13.69 | 2024 | Myfembree |
| Tonix Medicines, INC. | $13.68 | 2025 | Tonmya |
| Otsuka America Pharmaceutical, INC. | $13.24 | 2023 | Rexulti, Abilify Maintena |
| Phadia US INC. | $13.02 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.